Clinical trial for HIV Infections
Official title Screen2Prevent (S2P)
ClinicalTrials.gov ID: NCT07728123
What this study is testing
- What it's testing
- The study wants to learn which screening approach, targeted, universal opt‑in, or universal opt‑out, best finds HIV infections and connects adolescents to pre‑exposure prophylaxis (PrEP) or antiretroviral therapy (ART).
- Who it's for
- Adolescents who are seeking care in an emergency department.
- What's involved
- You will be screened for HIV using one of three methods and may receive digital tools to help you start PrEP or ART if needed; the visit includes questionnaires and possible follow‑up contacts.
- Time commitment
- Participation includes the emergency‑department visit and any follow‑up contacts; the overall time commitment varies by individual.
- Time commitment: about 24 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 14 to 24. Healthy volunteers may be eligible.
You may be able to join if
- Age 14-24 years, inclusive
- Present to the participating ED, regardless of chief complaint during the study period
You likely can't join if
- None
The study team makes the final eligibility decision.
Where it is enrolling
- Tampa, Florida, United States
- Atlanta, Georgia, United States
- Baltimore, Maryland, United States
- Memphis, Tennessee, United States
- Houston, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 24 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 14 years to 24 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Tampa, Florida, United States; Atlanta, Georgia, United States; Baltimore, Maryland, United States; Memphis, Tennessee, United States; Houston, Texas, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.